Sign up for email alerts to receive notifications of new articles published in Japanese Clinical Medicine
Nucleotide excision repair (NER) is an essential system for correcting ultraviolet (UV)—induced DNA damage. Lesions remaining in DNA due to reduced capacity of NER may result in cellular death, premature aging, mutagenesis and carcinogenesis of the skin. So, NER is an important protection against these changes. There are three representative genodermatoses resulting from genetic defects in NER: xeroderma pigmentosum (XP), Cockayne syndrome (CS), and trichothiodystrophy (TTD). In Japan, CS is similarly rare but XP is more common and TTD is less common compared to Western countries.
In 1998, we established the system for the diagnosis of these disorders and we have been performing DNA repair and genetic analysis for more than 400 samples since then. At present, there is no cure for any human genetic disorder. Early diagnosis and symptomatic treatment of neurological, ocular and dermatological abnormalities should contribute to prolonging life and elevating QOL in patients.
PDF (1.60 MB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
Drug Target Insight offers a rapid scientific evaluation of submitted manuscripts. The editorial staff is extremely helpful in the guidance through the process. By recruitment of several references, the review process has the chance to be more fair and objective compared with when only a single referee is used. I can strongly recommend to publish research articles in the journal.
Facebook Google+ Twitter
Pinterest Tumblr YouTube